Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Phillips

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Aging|February 22, 2018
Modified aging of elite athletes revealed by analysis of epigenetic age markersMagdalena Spólnicka, Ewelina Pośpiech, Jakub Grzegorz Adamczyk, et al.
Frontiers in Genetics|November 16, 2020
Broadening the Applicability of a Custom Multi-Platform Panel of Microhaplotypes: Bio-Geographical Ancestry Inference and Expanded Reference DataMaría de la Puente, Jorge Ruiz-Ramírez, Adrián Ambroa-Conde, et al.
Nature Communications|July 15, 2017
Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchangeSandrine Guillard, Paulina Kolasinska-Zwierz, Judit Debreczeni, et al.
Ebiomedicine|January 10, 2020
Structural insights and activating mutations in diverse pathologies define mechanisms of deregulation for phospholipase C gamma enzymesYang Liu, Tom D Bunney, Sakshi Khosa, et al.
Electrophoresis|August 14, 2018
Global patterns of STR sequence variation: Sequencing the CEPH human genome diversity panel for 58 forensic STRs using the Illumina ForenSeq DNA Signature Prep KitChristopher Phillips, Laurence Devesse, David Ballard, et al.
Nature Communications|June 15, 2019
KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobeNicolas Bery, Sandrine Legg, Judit Debreczeni, et al.
Chemical Biology & Drug Design|June 11, 2013
TAK1 inhibition in the DFG-out conformationIain Kilty, Martin P Green, Andrew S Bell, et al.
ACS Medicinal Chemistry Letters|September 19, 2019
Structural and Molecular Insight into Resistance Mechanisms of First Generation cMET InhibitorsGavin W Collie, Cheryl M Koh, Daniel J O'Neill, et al.
Journal of Medicinal Chemistry|April 24, 2007
Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-sulfonamidoisoquinolinyl)guanidinesPaul V Fish, Christopher G Barber, David G Brown, et al.
Aging|August 10, 2021
Epigenetic age prediction in semen - marker selection and model developmentAleksandra Pisarek, Ewelina Pośpiech, Antonia Heidegger, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Aging|February 22, 2018
Modified aging of elite athletes revealed by analysis of epigenetic age markersMagdalena Spólnicka, Ewelina Pośpiech, Jakub Grzegorz Adamczyk, et al.
Frontiers in Genetics|November 16, 2020
Broadening the Applicability of a Custom Multi-Platform Panel of Microhaplotypes: Bio-Geographical Ancestry Inference and Expanded Reference DataMaría de la Puente, Jorge Ruiz-Ramírez, Adrián Ambroa-Conde, et al.
Nature Communications|July 15, 2017
Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchangeSandrine Guillard, Paulina Kolasinska-Zwierz, Judit Debreczeni, et al.
Ebiomedicine|January 10, 2020
Structural insights and activating mutations in diverse pathologies define mechanisms of deregulation for phospholipase C gamma enzymesYang Liu, Tom D Bunney, Sakshi Khosa, et al.
Electrophoresis|August 14, 2018
Global patterns of STR sequence variation: Sequencing the CEPH human genome diversity panel for 58 forensic STRs using the Illumina ForenSeq DNA Signature Prep KitChristopher Phillips, Laurence Devesse, David Ballard, et al.
Nature Communications|June 15, 2019
KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobeNicolas Bery, Sandrine Legg, Judit Debreczeni, et al.
Chemical Biology & Drug Design|June 11, 2013
TAK1 inhibition in the DFG-out conformationIain Kilty, Martin P Green, Andrew S Bell, et al.
ACS Medicinal Chemistry Letters|September 19, 2019
Structural and Molecular Insight into Resistance Mechanisms of First Generation cMET InhibitorsGavin W Collie, Cheryl M Koh, Daniel J O'Neill, et al.
Journal of Medicinal Chemistry|April 24, 2007
Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-sulfonamidoisoquinolinyl)guanidinesPaul V Fish, Christopher G Barber, David G Brown, et al.
Aging|August 10, 2021
Epigenetic age prediction in semen - marker selection and model developmentAleksandra Pisarek, Ewelina Pośpiech, Antonia Heidegger, et al.
Pageof 13